Effects of the SGLT2 Inhibition on Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats, a Model of Type 1 Diabetes Mellitus

• المؤلفون الرئيسيون: Camila Moreno Rosa (مؤلف), Dijon Henrique Salome Campos (مؤلف), David Rafael Abreu Reyes (مؤلف), Felipe Cesar Damatto (مؤلف), Lucas Yamada Kurosaki (مؤلف), Luana Urbano Pagan (مؤلف), Mariana Janini Gomes (مؤلف), Camila Renata Corrêa (مؤلف), Ana Angelica Henrique Fernandes (مؤلف), Marina Politi Okoshi (مؤلف), Katashi Okoshi (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2022-05-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Clinical trials have shown that sodium glucose co-transporter 2 (SGLT2) inhibitors improve clinical outcomes in diabetes mellitus (DM) patients. As most studies were performed in Type 2 DM, the cardiovascular effects of SGLT2 inhibition still require clarification in Type 1 DM. We analyzed the effec...